Atovaquone Suspension
Product Images NDC 81033-104

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Atovaquone (NDC 81033-104). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kesin Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Chemical structure diagram of the active ingredient Atovaquone, showing its molecular framework including a chlorophenyl group and quinone moiety.*

FDA Label Image

Kesin Pharma Logo (Kesin Logo)

FDA Label Image

Atovaquone_42ct_carton_label (Atovaquone Os 5ml 42ct Carton)

Atovaquone Oral Suspension, USP 750 mg per 5 mL unit dose cups. The label indicates the product is for institutional use only, Rx only, packaged and distributed by Kesin Pharma Corporation, Oldsmar, FL. The package contains 42 x 5 mL unit dose cups. Storage instructions specify 68°F to 77°F (20°C to 25°C). Barcode and QR code are also present.*

FDA Label Image

Atovaquone_20ct_carton_label (Atovaquone Os 5ml 20ct Carton)

Label for Atovaquone Oral Suspension, USP 750 mg per 5 mL from Kesin Pharma. It delivers 5 mL and is packaged as 20 x 5 mL unit dose cups. The label states Rx Only and For Institutional Use Only, with storage instructions between 68°F to 77°F (20°C to 25°C). Includes NDC 81033-104-22 and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.